Heron Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Heron Therapeutics, Inc. (HRTX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.030.030.020.160.110.390.33
Short-Term Investments0.030.050.070.070.100.000.00
Cash & Short-Term Investments0.060.080.080.160.210.390.33
Accounts Receivable0.080.060.050.040.040.040.06
Inventory0.050.040.050.050.040.020.04
Other Current Assets0.020.010.010.010.020.000.00
Total Current Assets0.210.190.210.250.310.480.45
Non-Current Assets
Property, Plant & Equipment (Net)0.020.030.030.030.040.030.01
Other Non-Current Assets0.010.010.020.020.000.000.00
Total Non-Current Assets0.020.030.050.050.040.030.01
Total Assets0.230.220.250.310.350.510.46
Current Liabilities
Accounts Payable0.010.000.000.030.000.050.09
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.080.060.060.050.090.000.00
Other Current Liabilities0.070.010.040.020.000.000.00
Total Current Liabilities0.090.080.080.070.100.060.09
Non-Current Liabilities
Long-Term Debt0.170.170.150.160.010.010.00
Other Non-Current Liabilities0.000.000.000.020.050.030.00
Total Non-Current Liabilities0.180.180.160.180.060.050.00
Total Liabilities0.270.260.240.230.120.110.09
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.92-1.91-1.80-1.61-1.39-1.17-0.96
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.881.871.811.691.631.571.33
Shares Outstanding0.150.150.120.100.000.000.00
Total Stockholders' Equity-0.03-0.030.010.080.240.400.37
Total Liabilities & Equity0.230.220.250.310.350.510.46